Loading…
IGC Pharma, Inc. is projected to rise to $0.3498 by 2027, a +29% move from its current price of $0.272. IGC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.2671 | $0.2721 | $0.2772 | +0.04% |
| Jul 14 | $0.2652 | $0.2722 | $0.2795 | +0.09% |
| Jul 15 | $0.2637 | $0.2724 | $0.2813 | +0.13% |
| Jul 16 | $0.2625 | $0.2725 | $0.2828 | +0.18% |
| Jul 17 | $0.2615 | $0.2726 | $0.2842 | +0.22% |
| Jul 18 | $0.2606 | $0.2727 | $0.2854 | +0.27% |
| Jul 19 | $0.2598 | $0.2729 | $0.2866 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2598 | $0.2729 | $0.2866 | +0.31% |
| Week 2 | $0.2553 | $0.2737 | $0.2934 | +0.63% |
| Week 3 | $0.2522 | $0.2746 | $0.299 | +0.94% |
| Week 4 | $0.2496 | $0.2754 | $0.3039 | +1.26% |
| Week 5 | $0.2475 | $0.2763 | $0.3084 | +1.58% |
| Week 6 | $0.2457 | $0.2771 | $0.3126 | +1.89% |
| Week 7 | $0.2441 | $0.278 | $0.3166 | +2.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IGC Pharma, Inc. is a healthcare company focused on developing novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia.
Its lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's.
The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
IGC Pharma, Inc. trades at $0.2666 and has a market capitalization of $26.68M.
Its rank is 4516.
The near-term outlook shows a neutral stance for 2026, with a min of $0.25, an avg of $0.2666, and a max of $0.3509, reflecting a Neutral sentiment.
Beyond 2026, the forecast turns bullish, with 2027 avg $0.3441, 2028 avg $0.3797, 2029 avg $0.4161, and 2030 avg $0.4177, then rising further through 2031-2035, 2040, and 2050, with 2040 avg $0.9761 and 2050 avg $1.76. The max forecasts reach up to $2.93 and the implied ROI climbs to 559.3% by 2050.
A major floor 13.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.4% below — buyers have tended to step in here.
The nearest ceiling, 10.3% above — a clean break opens room to run.
A major ceiling 28.7% above — clearing it would confirm fresh momentum.
Key IGC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IGC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.278 | Sell | $0.2757 | Sell |
| MA 10 | $0.274 | Sell | $0.2753 | Sell |
| MA 20 | $0.274 | Sell | $0.2769 | Sell |
| MA 50 | $0.289 | Sell | $0.284 | Sell |
| MA 100 | $0.2883 | Sell | $0.2913 | Sell |
| MA 200 | $0.3128 | Sell | $0.3051 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.50 | Neutral |
| Stoch RSI (14) | 54.41 | Neutral |
| CCI (20) | -44.44 | Neutral |
| Williams %R (14) | -50.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 50.00 | Neutral |
| TRIX (15) | -0.26 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 48.81 | Neutral |
| Momentum (10) | 0.01 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 0.28 | Sell |
| ADX (14) | 15.65 | Neutral |
| ATR (14) | 0.00 | Info |
Bearish sentiment dominates near term.
RSI14 is 30, indicating potential short-term weakness.
SMA50 is $0.302 and SMA200 is $0.3222, suggesting a trading range around the current level. The 30-day range is $0.2334–$0.3045, with support at $0.27 and resistance at $0.31. Annualized volatility is 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.25 | $0.272 | $0.3521 | 0% | Neutral | |
| $0.2865 | $0.3498 | $0.4466 | +29% | Bullish | |
| $0.3071 | $0.382 | $0.5008 | +40% | Bullish | |
| $0.337 | $0.4257 | $0.57 | +57% | Bullish | |
| $0.3338 | $0.4273 | $0.5824 | +57% | Bullish | |
| $0.3445 | $0.4464 | $0.618 | +64% | Bullish | |
| $0.3871 | $0.5072 | $0.7123 | +86% | Bullish | |
| $0.4068 | $0.5386 | $0.7662 | +98% | Bullish | |
| $0.4746 | $0.6347 | $0.9136 | +133% | Bullish | |
| $0.5323 | $0.7186 | $1.05 | +164% | Bullish | |
| $0.6917 | $0.974 | $1.49 | +258% | Bullish | |
| $1.19 | $1.80 | $2.94 | +560% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.25 | $0.272 | $0.3217 | +0.00% |
| August 2026 | $0.239 | $0.2797 | $0.3345 | +2.83% |
| September 2026 | $0.2409 | $0.2833 | $0.3414 | +1.29% |
| October 2026 | $0.2345 | $0.277 | $0.336 | -2.23% |
| November 2026 | $0.2341 | $0.2775 | $0.3385 | +0.18% |
| December 2026 | $0.2416 | $0.2872 | $0.3521 | +3.50% |
Click any year to see its month-by-month IGC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, IGC could reach as high as $0.3521, with a base case around $0.272 and support toward $0.25 — roughly 0% from $0.272. Price action looks broadly range-bound.
Expect IGC to range from $0.2865 to $0.4466 through 2027. The $0.3498 average target implies a +29% move from current prices. That is up +29% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The IGC price prediction for 2028 points to an average of $0.382 (low $0.3071, high $0.5008) — a potential gain of +40% on today's $0.272. Momentum favours further upside here.
In 2029, IGC is projected to trade between $0.337 and $0.57, averaging $0.4257 — a potential gain of +57% from today's $0.272. That is up +11% on the projected 2028 average. Buyers look set to stay in control over this stretch.
IGC Pharma, Inc.'s 2030 outlook centres on $0.4273, within a $0.3338 to $0.5824 range. That is up 0% on the projected 2029 average. That marks a +57% change versus current levels. Momentum favours further upside here.
By 2031, IGC could reach as high as $0.618, with a base case around $0.4464 and support toward $0.3445 — roughly +64% from $0.272. Buyers look set to stay in control over this stretch.
Expect IGC to range from $0.3871 to $0.7123 through 2032. The $0.5072 average target implies a +86% move from current prices. That is up +14% on the projected 2031 average. Momentum favours further upside here.
The IGC price prediction for 2033 points to an average of $0.5386 (low $0.4068, high $0.7662) — a potential gain of +98% on today's $0.272. Buyers look set to stay in control over this stretch.
In 2034, IGC is projected to trade between $0.4746 and $0.9136, averaging $0.6347 — a potential gain of +133% from today's $0.272. That is up +18% on the projected 2033 average. Momentum favours further upside here.
IGC Pharma, Inc.'s 2035 outlook centres on $0.7186, within a $0.5323 to $1.05 range. That is up +13% on the projected 2034 average. That marks a +164% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, IGC could reach as high as $1.49, with a base case around $0.974 and support toward $0.6917 — roughly +258% from $0.272. Momentum favours further upside here.
Expect IGC to range from $1.19 to $2.94 through 2050. The $1.80 average target implies a +560% move from current prices. That is up +84% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in IGC today (≈ 3,676.470588 IGC) could be worth
$6,600.2
+$5,600.2 (+560%) by 2050 · US Dollar
Based on the average projected IGC price of $1.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IGCwould be worth at today's price.
$1,000 invested in IGC on Jul 10, 2025 (≈ 2,380.952455 IGC) would be worth
$647.62
-$352.38 (-35.2%) today · 0.65× · US Dollar
Based on a IGC entry price of $0.42 vs. today's $0.272.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.28 | $971.43 | -2.9% |
| 1 month ago | $0.28 | $971.43 | -2.9% |
| 3 months ago | $0.3 | $906.67 | -9.3% |
| 6 months ago | $0.3 | $906.67 | -9.3% |
| 1 year ago | $0.42 | $647.62 | -35.2% |
| All time (5.0y) ago | $1.48 | $183.78 | -81.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IGC forecast.
Our base-case forecast reaches $0.54 around 2034.
Implied market cap at $0.54: $56.36M
The multi-year forecast shows a bullish trajectory after 2026. In 2027 the avg is $0.3441 with min $0.2802, max $0.4429 and a Bullish sentiment, yielding a 29.1% ROI.
In 2028 the avg is $0.3797, min $0.3032, max $0.5025, with a 42.4% ROI; 2029 the avg is $0.4161, min $0.3268, max $0.5631, with a 56.1% ROI; 2030 the avg is $0.4177, min $0.3234, max $0.5759, with a 56.7% ROI.
From 2031 onward the forecast remains bullish, with 2031 avg $0.446, max $0.6252 and 67.3% ROI; 2032 avg $0.4983, max $0.7089 and 86.9% ROI; 2033 avg $0.5255, max $0.7579 and 97.1% ROI; 2034 avg $0.6354, max $0.928 and 138.3% ROI; 2035 avg $0.712, max $1.05 and 167.1% ROI.
On the longer horizon, 2040 shows avg $0.9761 with max $1.51 and 266.1% ROI, and 2050 projects avg $1.76 with max $2.93 and 559.3% ROI. The sentiment remains BULLISH across the longer horizon. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
The forecast for 2030 lists min $0.3234, avg $0.4177, max $0.5759, with an ROI of 56.7% and a BULLISH sentiment.
The forecast shows a bullish trend from 2027 onward with rising averages and positive ROIs (e.g., 2027 ROI 29.1%, 2032 ROI 86.9%, 2050 ROI 559.3%). The near-term 2026 forecast is Neutral, and the current price is $0.2666 with a market cap of $26.68M.
Yes. The forecast max for 2035 is $1.05, and the max for 2040 is $1.51, with the 2050 max at $2.93.
Current price is $0.2666 and market capitalization is $26.68M.
For 2027 the avg is $0.3441, min $0.2802, max $0.4429, with a 29.1% ROI and a BULLISH sentiment.
IGC Pharma, Inc. Community Discussion
0Share your IGC Pharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.